Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Case 95 - Myastheniccrisis

  • from Section II - Neurocritical care
  • Edited by George A. Mashour, Ehab Farag
  • Book:
    Case Studies in Neuroanesthesia and Neurocritical Care
    Published online:
    03 May 2011
    Print publication:
    03 February 2011, pp 321-323

  • Summary

    The major factors in predicting neurologic dysfunction secondary to cardiac arrest involve the extent of brain insult as a function of time to return of circulation. The use of induced hypothermia has been studied as a way to combat neurologic injury for nearly five decades. This chapter presents a case study of a 37-year-old female with a history of chronic back pain and depression following a witnessed cardiac arrest 1 week after beginning risperidone therapy. The use of therapeutic hypothermia is widely accepted as the standard of care for preserving neurologic function following cardiac arrest. Cooling should be performed in all postcardiac arrest patients regardless of documented dysrhythmia, but supportive data are strongest for patients who are post ventricular fibrillation. Therapeutic hypothermia has been shown to be relatively safe and effective, and should be considered in the treatment of comatose patients following cardiac arrest.